Sqz Biotechnologies Co Stock Price To Earnings To Growth
| SQZDelisted Stock | USD 0.10 0.04 28.57% |
Sqz Biotechnologies Co fundamentals help investors to digest information that contributes to Sqz Biotechnologies' financial success or failures. It also enables traders to predict the movement of Sqz Stock. The fundamental analysis module provides a way to measure Sqz Biotechnologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sqz Biotechnologies stock.
Sqz |
Sqz Biotechnologies Co Company Price To Earnings To Growth Analysis
Sqz Biotechnologies' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Sqz Biotechnologies Price To Earnings To Growth | (0.03) X |
Most of Sqz Biotechnologies' fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sqz Biotechnologies Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Sqz Biotechnologies Co has a Price To Earnings To Growth of -0.03 times. This is 104.23% lower than that of the Biotechnology sector and 100.96% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.61% higher than that of the company.
Sqz Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sqz Biotechnologies' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sqz Biotechnologies could also be used in its relative valuation, which is a method of valuing Sqz Biotechnologies by comparing valuation metrics of similar companies.Sqz Biotechnologies is currently under evaluation in price to earnings to growth category among its peers.
Sqz Fundamentals
| Return On Equity | -1.05 | |||
| Return On Asset | -0.33 | |||
| Operating Margin | (3.92) % | |||
| Current Valuation | (6.5 M) | |||
| Shares Outstanding | 29.49 M | |||
| Shares Owned By Insiders | 3.12 % | |||
| Shares Owned By Institutions | 66.58 % | |||
| Number Of Shares Shorted | 811.15 K | |||
| Price To Book | 0.50 X | |||
| Price To Sales | 1.24 X | |||
| Revenue | 21.03 M | |||
| Gross Profit | (43.05 M) | |||
| EBITDA | (59.28 M) | |||
| Net Income | (79.46 M) | |||
| Cash And Equivalents | 63.71 M | |||
| Cash Per Share | 3.61 X | |||
| Total Debt | 27.47 M | |||
| Debt To Equity | 0.74 % | |||
| Current Ratio | 3.87 X | |||
| Book Value Per Share | 1.36 X | |||
| Cash Flow From Operations | (83.55 M) | |||
| Short Ratio | 27.26 X | |||
| Earnings Per Share | (2.16) X | |||
| Price To Earnings To Growth | (0.03) X | |||
| Target Price | 19.0 | |||
| Number Of Employees | 53 | |||
| Beta | 2.71 | |||
| Market Capitalization | 12.83 M | |||
| Total Asset | 99.9 M | |||
| Retained Earnings | (274.97 M) | |||
| Working Capital | 46.36 M | |||
| Z Score | -4.76 | |||
| Net Asset | 99.9 M |
About Sqz Biotechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sqz Biotechnologies Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sqz Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sqz Biotechnologies Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Sqz Stock
If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |